Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...

The FDA has cleared Abbott’s Confirm Rx Insertable Cardiac Monitor (ICM), an implantable device that continuously tracks patients’ heart rhythms and sends the data to a smartphone app via Bluetooth.

Following up on the cardiac abnormality thankfully detected by wearable devices, this engineer details the system he donned ...

Abbott's Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM offers long ...

Heartbeam, Inc. ( (BEAT)) has released its Q3 earnings. Here is a breakdown of the information Heartbeam, Inc. presented to its investors. HeartBeam, Inc. is an innovative medical technology company ...

Nearly 700,000 people in the United States die from heart disease every year, and one-third of those deaths result from complications in the first weeks or months following a traumatic heart-related ...

Increasing Demand for ECMO Systems, Portable Devices, and Pediatric Cardiac Support, Along with Expanding Hospital Infrastructure and Smart Monitoring Innovations, Fuel Market Growth.Austin, United ...

Nearly 200 million people around the globe have coronary heart disease, which accounts for about one in every six deaths, according to the British Heart Foundation. That's why the recent and rapid ...

A remote monitoring system being implemented at hospitals in Oxnard and Camarillo means heart rhythms of patients at risk of cardiac arrests and other problems are being tracked by technicians 430 ...